Clinical Trials Browser

Observational × Prostatic Neoplasms × relugolix × Clear all

NCT05467176 2026-04-08

OPTYX

Active not recruiting

Prostatic Neoplasms

NCT06462014 2025-12-11

Description of Relugolix Use in Patients With Prostate Cancer Within the VHA

507 enrolled 13 charts

Prostatic Neoplasms